All In Biotech

Drug Trial Radar · NCT00198510

Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage

Phase III Safety and Efficacy Study of Vitrase (Ovine Hyaluronidase) for Ophthalmic Intravitreal Injection for Clearance of Severe Vitreous Hemorrhage

Last checked: Nov 20, 2026Latest source record: Mar 15, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 750 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

750

Actual

Start

Nov 1998

Primary completion

Sep 2001

Study completion Mar 2003

Sponsor

Lead sponsor
Bausch & Lomb IncorporatedIndustry
Sponsor type
Industry
First posted
Sep 20, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine if intravitreal injection of Vitrase (ovine hyaluronidase) clears vitreous hemorrhage

Conditions

  • Vitreous Hemorrhage
  • Diabetic Retinopathy

Interventions

  • VitraseDrug

    7.5 IU of Vitrase

  • VitraseDrug

    55 IU of Vitrase

  • VitraseDrug

    75 IU of Vitrase

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Resolution of Vitreous HemorrhageTime frame: 3 months

Locations

73 sites in 3 countries. Site status is shown where the registry gives one.

  • Retina Centers, PC

    Tucson, Arizona

  • Retina Vitreous Associates Medical Group

    Beverly Hills, California

  • Maria E. Castillejos, MD

    Chula Vista, California

  • Natural Vision

    Fresno, California

  • Eye Medical Center of Fresno

    Fresno, California

  • Jerry Sebag, MD

    Huntington Beach, California

  • University of California, Irvine

    Irvine, California

  • California VitreRetinal Center

    Menlo Park, California

  • Southern California Desert Retina Consultants

    Palm Springs, California

  • Retinal Consultants

    Sacramento, California

  • H. Richard McDonald, MD

    San Francisco, California

  • Santa Clara Valley Medical Centre

    San Jose, California

  • Robert L. Avery, MD

    Santa Barbara, California

  • Olive View/UCLA Medical Center

    Sylmar, California

  • Retina Consultants of Southern Colorado

    Colorado Springs, Colorado

  • University of Colorado Health Sciences Center

    Denver, Colorado

  • Danbury Eye Physicians & Surgeons

    Danbury, Connecticut

  • New England Retina Associates

    Hamden, Connecticut

  • Florida Eye Clinic

    Altamonte Springs, Florida

  • Eye Centers of Florida

    Fort Myers, Florida

  • Sarasota Retina Institute

    Sarasota, Florida

  • Scott E. Pautler, MD

    Tampa, Florida

  • Retina Center at Pali Momi

    ‘Aiea, Hawaii

  • Illinois Retina Associates SC

    Chicago, Illinois

  • University of Chicago

    Chicago, Illinois

  • American Eye Institute

    New Albany, Indiana

  • Felix N. Sabates Eye Associates

    Prairie Village, Kansas

  • King Y. Lee, MD

    Shawnee Mission, Kansas

  • Kurt A. Gitter, MD

    New Orleans, Louisiana

  • Retina Specialists

    Baltimore, Maryland

  • Wilmer Eye Institute/Johns Hopkins University School of Medicine

    Baltimore, Maryland

  • Retina Consultants, PC

    Bethesda, Maryland

  • Schepens Retina Associates

    Boston, Massachusetts

  • VitreoRetinal Associates

    Grand Rapids, Michigan

  • Retina Center PA

    Minneapolis, Minnesota

  • Hunkeler Eye Centers

    Kansas City, Missouri

  • Retina Associates of Kansas City

    Kansas City, Missouri

  • The Center for Advanced Medicine/Barnes Retina Institute

    St Louis, Missouri

  • Robert Wood Johnson Medical School/Retina Vitreous Center

    New Brunswick, New Jersey

  • Retina Associates of New Jersey

    Teaneck, New Jersey

Showing 40 of 73 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.